Development and usability testing of a patient decision aid to enhance shared decision-making regarding treatment decision in type 2 diabetes

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21109

Enrollment

270

Registered

2020-10-05

Start date

2020-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: Patients: - Diagnosed type 2 diabetes - Duration of diabetes > 1 year - HbA1c: 7.0-10.5% - = 40 years - Treated in first line in step (metformin) or sept 2 (metformin + sulfonylurea) according to the NHG guidelines Healthcare providers: - GP, practice nurse or diabetes nurse - Currently working in primary care - Experience in treating adult patients with type 2 diabetes for at least 2 years

Exclusion criteria

Exclusion criteria: - Patients that are treated with other antihyperglycemic agents other than metformin and/or sulfonylurea are not included in this study

Design outcomes

Primary

Measure	Time frame
Collect and generate patient-preference data specific for type 2 diabetes treatment in a scientific robust approach that ultimately can be used to visualize an attractive and practical patient decision aid to support the choice of glucose-lowering drugs.	—

Secondary

Measure	Time frame
- To identify which items – or attributes – patients with type 2 diabetes consider to be important for decision making in type 2 diabetes glucose-lowering drug treatment - To develop a shortlist of 5-15 prioritized patient preferred attributes - To develop several PDA concepts and discuss their usability with patients and healthcare providers	—

Contacts

Public ContactAnna Tichler

University of Maastricht

a.tichler@maastrichtuniversity.nl+31 43 38 82 193

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)